Therapy escape mechanisms in the malignant prostate

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Androgen receptor (AR) is a primary target in prostate cancer treatment.
• Current therapies include chemical castration, androgen synthesis inhibition, and anti-androgens.
• Treatment resistance is a significant clinical challenge in managing prostate cancer.

Purpose of the Study:

• To summarize current knowledge on molecular mechanisms of therapy resistance in prostate cancer.
• To categorize tumor escape mechanisms for better understanding and comparison.
• To aid researchers in comparing resistance mechanisms across different cancer types.

Main Methods:

• Literature review and synthesis of existing research on prostate cancer therapy resistance.
• Categorization of identified molecular mechanisms into distinct concepts.
• Comparative analysis of resistance mechanisms within prostate cancer and other malignancies.

Main Results:

• Identified key molecular mechanisms driving therapy resistance in prostate cancer.
• Organized escape mechanisms into categories: target modification, bypass signaling, histologic transformation, cancer stem cells, and miscellaneous.
• Highlighted the heterogeneity of resistance pathways.

Conclusions:

• Therapy resistance in prostate cancer is multifactorial, involving complex molecular alterations.
• A structured understanding of these mechanisms facilitates research and therapeutic development.
• This framework can be applied to compare resistance strategies in various cancer types.